Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Predicting in vivo anti-hepatofibrotic drug efficacy based on in vitro high-content analysis.

Baixue Zheng | Looling Tan | Xuejun Mo | Weimiao Yu | Yan Wang | Lisa Tucker-Kellogg | Roy E Welsch | Peter T C So | Hanry Yu
PloS one | 2011

Many anti-fibrotic drugs with high in vitro efficacies fail to produce significant effects in vivo. The aim of this work is to use a statistical approach to design a numerical predictor that correlates better with in vivo outcomes.

Pubmed ID: 22073152

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


LX-2 (tool)

RRID:CVCL_5792

Cell line LX-2 is a Transformed cell line with a species of origin Homo sapiens

View all literature mentions